Coordinated Clinical Care For CAR T Lymphoma Patients a Multidisciplinary Approach

Panelists discuss how CAR T-cell therapy has evolved from a highly toxic inpatient treatment to a safer, increasingly accessible therapy that can often be administered on an outpatient basis, with improved patient outcomes when referred early in the treatment journey and enhanced collaboration between academic centers and community oncologists for optimal patient care.